5 Fluorouracil Sensitivity |
2012166 | Dihydropyrimidine Dehydrogenase (DPYD) Genotyping, 3 Mutations | |
Achondroplasia |
0051266 | Achondroplasia (FGFR3) 2 Mutations | |
0051265 | Achondroplasia Mutation, Fetal | |
Acylcarnitine |
0081110 | Carnitine Panel | |
0040033 | Acylcarnitine Quantitative Profile, Plasma | |
Acylglycine |
0081170 | Acylglycine, Quantitative, Urine | |
Alpha Fetoprotein, Aminotic Fluid |
3000142 | Alpha Fetoprotein (Amniotic Fluid) with Reflex to Acetylcholinesterase and Fetal Hemoglobin | |
Alpha Thalassemia |
3003651 | Alpha Thalassemia (HBA1 and HBA2) Deletion/Duplication with Reflex to Hb Constant Spring | |
2011622 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication | |
2011708 | Alpha Globin (HBA1 and HBA2) Sequencing and Deletion/Duplication | |
3003656 | Alpha Thalassemia (HBA1 and HBA2) Deletion/Duplication with Reflex to Hb Constant Spring, Fetal | |
Alpha-1-Antitrypsin |
0051256 | Alpha-1-Antitrypsin & A1A Genotype with Reflex to Phenotype | |
Alport Syndrome |
3002685 | Alport Syndrome Panel, Sequencing and Deletion/Duplication | |
Alzheimer's Disease |
3001585 | Early-Onset Alzheimer's Panel, Sequencing | |
2013341 | Apolipoprotein E (APOE) Genotyping, Alzheimer Disease Risk | |
Amino Acids |
2009389 | Amino Acids Quantitative by LC-MS/MS, Plasma | |
2009419 | Amino Acids Quantitative by LC-MS/MS, Urine | |
0080137 | Amino Acids Quantitative, CSF | |
Angelman Syndrome |
3006247 | Angelman Syndrome and Prader-Willi Syndrome by Methylation-Specific MLPA | |
2002299 | Chromosome FISH, Metaphase—Angelman syndrome (15q11.2-13) | |
Aortopathies |
2006540 | Aortopathy Panel, Sequencing and Deletion/Duplication | |
3003947 | Loeys-Dietz Syndrome Core Panel, Sequencing | |
3004102 | Marfan Syndrome (FBN1) Sequencing and Deletion/Duplication | |
2013341 | Apolipoprotein E (APOE) Genotyping, Alzheimer Disease Risk | |
2013337 | Apolipoprotein E (APOE) Genotyping, Cardiovascular Risk | |
Arthrogryposis |
3003917 | Distal Arthrogryposis Panel, Sequencing | |
Ashkenazi Jewish Panel (16 disorders) |
0051415 | Ashkenazi Jewish Diseases, 16 Genes | |
2013725 | ABCC8-Related Hyperinsulinism, 3 Variants | |
0051433 | Bloom Syndrome (BLM),1 Variant | |
0051453 | Canavan Disease (ASPA), 4 Variants | |
3005882 | Dysautonomia, Familial (ELP1), 2 Variants | |
0051468 | Fanconi Anemia Group C, (FANCC), 2 Variants | |
0051438 | Gaucher Disease (GBA), 8 Variants | |
2013740 | Glycogen Storage Disease, Type 1A (G6PC), 9 Variants | |
2013909 | Joubert Syndrome Type 2 (TMEM216), 1 Variant | |
2013735 | Lipoamide Dehydrogenase Deficiency (DLD), 2 Variants | |
2013730 | Maple Syrup Urine Disease, Type 1B (BCKDHB), 3 Variants | |
0051448 | Mucolipidosis Type IV (MCOLN1), 2 Variants | |
2013745 | NEB-Related Nemaline Myopathy, 1 Variant | |
0051458 | Niemann-Pick, Type A (SMPD1), 4 Variants | |
0051428 | Tay-Sachs Disease (HEXA), 7 Variants | |
2013750 | Usher Syndrome, Types 1F and 3 (PCDH15 and CLRN1), 2 Variants | |
Autism |
2014314 | Autism and Intellectual Disability Comprehensive Panel | |
2003414 | Cytogenomic SNP Microarray | |
2006267 | Cytogenomic SNP Microarray Buccal Swab | |
2014312 | Autism and Intellectual Disability Metabolic Panel | |
Beckwith-Wiedemann |
3001635 | Beckwith-Wiedemann Syndrome (BWS) and Russell-Silver Syndrome (RSS) by Methylation-Specific MLPA | |
Beta Globin |
3004547 | Beta Globin (HBB) Gene Sequencing | |
|
3004550 | Beta Globin (HBB) Sequencing, Fetal | |
3003144 | Deletion/Duplication Analysis by MLPA | |
Biotinidase |
0093362 | Biotinidase, Serum (with paired normal control) | |
Biotinidase Deficiency |
3004424 | Biotinidase Deficiency (BTD) Sequencing | |
Birt-Hogg-Dubé Syndrome |
3005703 | Birt-Hogg-Dubé Syndrome (FLCN) Sequencing and Deletion/Duplication | |
Blood Genotyping |
0051368 | Rh Genotyping D Antigen (RhD positive/negative and RhD copy number) | |
3016640 | RhD Gene (RHD) Copy Number, Fetal | |
3002002 | RhC/c (RHCE) Antigen Genotyping | |
3016679 | RhC/c (RHCE) Antigen Genotyping, Fetal | |
3002003 | RhE/e (RHCE) Antigen Genotyping | |
3016682 | RhE/e (RHCE) Antigen Genotyping, Fetal | |
3002001 | Kell K/k Antigen (KEL) Genotyping | |
3016676 | Kell K/k (KEL) Antigen Genotyping, Fetal | |
3001053 | Red Blood Cell Antigen Genotyping | |
3016639 | Red Blood Cell Antigen Genotyping, Fetal | |
Bone Marrow Failure |
3001615 | Hereditary Bone Marrow Failure Panel, Sequencing and Deletion/Duplication | |
Breast Cancer |
3005654 | Hereditary Breast Cancer High-Risk Panel, Sequencing and Deletion/Duplication | |
3005632 | Hereditary Breast Cancer Guidelines-Based Panel, Sequencing and Deletion/Duplication | |
2012026 | Hereditary Breast and Gynecological Cancers Panel, Sequencing and Deletion/Duplication | |
3001855 | BRCA1 and BRCA2-Associated HBOC Syndrome Panel, Sequencing and Deletion/Duplication | |
2012032 | Hereditary Cancer Panel, Sequencing and Deletion/Duplication | |
CADASIL |
3004383 | Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy, CADASIL | |
Capillary Malformation-Arteriovenous Malformation (CM-AVM) |
3003634 | Capillary Malformation-Arteriovenous Malformation (CM-AVM) Panel, Sequencing and Deletion/Duplication | |
3003144 | Deletion/Duplication Analysis by MLPA | |
Cardiomyopathy |
2010183 | Cardiomyopathy and Arrhythmia Panel, Sequencing and Deletion/Duplication | |
3001579 | Hypertrophic Cardiomyopathy Panel, Sequencing | |
3001581 | Dilated Cardiomyopathy Panel, Sequencing | |
3001603 | Long QT Panel, Sequencing and Deletion/Duplication | |
Carnitine |
0081110 | Carnitine Panel | |
0080068 | Carnitine, Free and Total, Plasma | |
0081308 | Carnitine, Free and Total, Urine | |
3006178 | Isobutyryl/butyryl-carnitine (C4) Quantitative, Urine | |
Carrier Screening Panels |
0051415 | Ashkenazi Jewish Diseases, 16 Genes | |
3000258 | Genetic Carrier Screen, (CF, FXS, and SMA) with Reflex to Methylation | |
2014680 | Expanded Carrier Screen by Next Generation Sequencing | |
2014677 | Expanded Carrier Screen by Next Generation Sequencing with Fragile X | |
Celiac Disease |
3004445 | Celiac Disease HLA-DQ Genotyping | |
Central Nervous System Cancer |
3001633 | Hereditary Central Nervous System Cancer Panel, Sequencing and Deletion/Duplication | |
Cerebral Cavernous Malformation |
3002286 | Cerebral Cavernous Malformation Panel, Sequencing and Deletion/Duplication | |
Charcot-Marie-Tooth Disease |
2012160 | Charcot-Marie-Tooth Type 1A (CMT1A)/Hereditary Neuropathy with Liability to Pressure Palsies (HNPP), PMP22 Deletion/Duplication | |
2012155 | Charcot-Marie-Tooth (CMT) and Related Hereditary Neuropathies, PMP22 Deletion/ Duplication with Reflex to Sequencing Panel | |
Chimerism |
3005449 | Chimerism, Pretransplant | |
3005462 | Chimerism, Donor | |
3005468 | Chimerism, Additional Donor | |
3005454 | Chimerism, Posttransplant | |
3005401 | Chimerism, Posttransplant, Sorted Cells (B Cells) | |
3005441 | Chimerism, Posttransplant, Sorted Cells (CD 56+ Cells) | |
3005409 | Chimerism, Posttransplant, Sorted Cells (CD33+ Cells) | |
3005433 | Chimerism, Posttransplant, Sorted Cells (CD34+ Cells) | |
3005417 | Chimerism, Posttransplant, Sorted Cells (Granulocytes) | |
3005425 | Chimerism, Posttransplant, Sorted Cells (Monocytes) | |
3005393 | Chimerism, Posttransplant, Sorted Cells (T Cells) | |
Cobalamin/Propionate/Homocysteine Metabolism Related Disorders |
2011157 | Cobalamin/Propionate/Homocysteine Metabolism Related Disorders Panel, Sequencing and Deletion/Duplication | |
Constitutional Chromosome Studies |
2002289 | Chromosome Analysis, Peripheral Blood | |
2002287 | Chromosome Analysis, Rule Out Mosaicism | |
2005763 | Chromosome Analysis, Peripheral Blood, with Reflex to Genomic Microarray | |
2002293 | Chromosome Analysis, Amniotic Fluid | |
2008367 | Chromosome Analysis, Amniotic Fluid, with Reflex to Genomic Microarray | |
2011130 | Chromosome FISH, Amniotic Fluid with Reflex to Chromosome Analysis or Genomic Microarray | |
2002291 | Chromosome Analysis, Chorionic Villus Sampling (CVS) | |
2011131 | Chromosome FISH, CVS with Reflex to Chromosome Analysis or Genomic Microarray | |
2002288 | Chromosome Analysis, Products of Conception | |
2005762 | Chromosome Analysis, Products of Conception, with Reflex to Genomic Microarray | |
2002286 | Chromosome Analysis, Skin Biopsy | |
0097688 | Chromosome Analysis—Breakage, Fanconi Anemia | |
Creatine |
2002328 | Creatine Disorders Panel, Plasma or Serum | |
2002333 | Creatine Disorders Panel, Urine | |
2002343 | Creatine, Urine | |
2002340 | Creatine, Serum or Plasma | |
Cystic Fibrosis |
3004745 | Cystic Fibrosis (CFTR) Sequencing and Deletion/Duplication | |
2013661 | Cystic Fibrosis (CFTR) Expanded Variant Panel | |
2013662 | Cystic Fibrosis (CFTR) Expanded Variant Panel, Fetal | |
Cystine |
0081105 | Cystinuria Panel (Arginine, Cystine, Lysine, Ornithine), Urine | |
0081106 | Cystine Quantitative, Urine | |
Cytochrome P450 |
3001524 | Cytochrome P450 Genotyping Panel | |
3004255 | Cytochrome P450 Genotyping Panel, with GeneDose Access | |
3004310 | CYP2B6 | |
3001508 | CYP2C19 | |
3001501 | CYP2C8, CYP2C9, and CYP2C cluster | |
3001513 | CYP2D6 | |
3001518 | CYP3A4 and CYP3A5 | |
Epilepsy |
3001591 | Comprehensive Epilepsy Panel, Sequencing and Deletion/Duplication | |
2013352 | Pyridoxine-Dependent Epilepsy Panel, Serum or Plasma | |
2013355 | Pyridoxine-Dependent Epilepsy Panel, Urine | |
Erythrocytosis |
3005721 | Hereditary Erythrocytosis Panel, Sequencing | |
Exome |
3016583 | Exome Sequencing | |
3016589 | Exome Sequencing, Familial Control | |
3001457 | Exome Reanalysis (Originally Test at ARUP - No Specimen Required) | |
Fabry Disease |
2003204 | Alpha-Galactosidase, Serum | |
Factor V Leiden |
0030192 | APC Resistance Profile with Reflex to Factor V Leiden | |
0097720 | Factor V Leiden (F5) R506Q Mutation | |
Factor XIII (F13A1) V34L Variant |
2003220 | Factor XIII (F13A1) V34L Variant (assess thrombotic risk in Caucasians) | |
Familial Adenomatous Polyposis |
3004407 | APC- and MUTYH-Associated Polyposis Panel, Sequencing and Deletion/Duplication | |
Familial Hypercholesterolemia |
3002110 | Familial Hypercholesterolemia Panel, Sequencing | |
Familial Mutation Testing |
3005867 | Familial Targeted Sequencing | |
3005869 | Familial Targeted Sequencing, Fetal | |
Familial Transthyretin Amyloidosis (TTR) |
3004531 | Familial Transthyretin Amyloidosis (TTR) | |
Fatty Acids |
3003086 | Fatty Acids Profile, Essential in Red Blood Cells | |
2013518 | Fatty Acids Profile, Essential Serum or Plasma | |
Fatty Acid Oxidation Disorders |
3001851 | Fatty Acid Oxidation Disorders Panel, Sequencing | |
0051205 | Medium Chain Acyl-CoA Dehydrogenase (ACADM) 2 Mutations | |
3004419 | Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (ACADVL) Sequencing and Deletion/Duplication | |
FISH (Constitutional)—Aneuploidy Panels |
0040208 | Aneuploidy Panel by FISH (13, 18, 21, X, & Y—newborn whole blood) | |
0040203 | Chorionic Villus, FISH (13, 18, 21, X, & Y—CVS) | |
2011130 | Chromosome FISH, Amniotic Fluid with Reflex to Chromosome Analysis or Genomic Microarray | |
2002297 | Chromosome FISH, Prenatal (13, 18, 21, X, & Y—Amniotic Fluid) | |
2011131 | Chromosome FISH, CVS with Reflex to Chromosome Analysis or Genomic Microarray | |
FISH (Constitutional)—Aneuploidy Panels with Reflex Testing |
2011130 | Chromosome FISH, Amniotic Fluid with Reflex to Chromosome Analysis or Genomic Microarray | |
2011131 | Chromosome FISH, CVS with Reflex to Chromosome Analysis or Genomic Microarray | |
FISH (Constitutional)—Individual Metaphase Probes |
2002299 | Chromosome FISH, Metaphase—15q11.2-13 duplication (15q11.2-13) | |
2002299 | Chromosome FISH, Metaphase—Cri-du-chat (5p-) syndrome (5p15.2) | |
2002299 | Chromosome FISH, Metaphase—DiGeorge/Velocardiofacial (VCF) syndrome (22q11.2) | |
2002299 | Chromosome FISH, Metaphase—Kallmann syndrome (Xp22.3) | |
2002299 | Chromosome FISH, Metaphase—Miller-Dieker (Lisencephaly) syndrome (17p13.3) | |
2002299 | Chromosome FISH, Metaphase—Phelan McDermid (22qter) syndrome (22q13.3) | |
2002299 | Chromosome FISH, Metaphase—Prader-Willi syndrome (15q11.2-13) | |
2002299 | Chromosome FISH, Metaphase—SHOX (Xp22.3) | |
2002299 | Chromosome FISH, Metaphase—Smith-Magenis syndrome (17p11.2) | |
2002299 | Chromosome FISH, Metaphase—SRY/male detection (Yp11.3) | |
2002299 | Chromosome FISH, Metaphase—Steroid sulfatase deficiency (STS) (Xp22.3) | |
2002299 | Chromosome FISH, Metaphase—Williams (elastin) syndrome (7q11.23) | |
2002299 | Chromosome FISH, Metaphase—Wolf-Hirschhorn (4p-) syndrome (4p16.3) | |
2002299 | Chromosome FISH, Metaphase—Yq12 | |
2002299 | Chromosome FISH, Metaphase—Angelman syndrome (15q11.2-13) | |
FISH (Constitutional)—Individual Interphase Probes |
2002298 | Chromosome FISH, Interphase—X centromere | |
2002298 | Chromosome FISH, Interphase—Y centromere | |
Fragile X |
2009033 | Fragile X (FMR1) with Reflex to Methylation Analysis | |
2009034 | Fragile X (FMR1) with Reflex to Methylation Analysis, Fetal | |
G6PD Deficiency |
3004457 | Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD) Sequencing | |
0051684 | Glucose-6-Phosphate Dehydrogenase (G6PD), DNA Mutation, African Alleles (A376G, G202A) | |
Galactosemia |
3001790 | Galactose-1-Phosphate Uridyltransferase (GALT Enzyme), RBC | |
0051175 | Galactosemia, (GALT) Enzyme Activity & 9 Mutations | |
0051176 | Galactosemia, (GALT) 9 Mutations | |
3004716 | Galactosemia (GALT) Sequencing and Deletion/Duplication | |
0081296 | Galactose-1-Phosphate in Red Blood Cells | |
0051270 | Galactosemia, (GALT ) 9 Mutations, Fetal | |
Gastrointestinal Cancer |
3005963 | Hereditary Gastric Cancer Panel, Sequencing and Deletion/Duplication | |
3005697 | Hereditary Gastrointestinal Cancer High-Risk Panel, Sequencing and Deletion/Duplication | |
2013449 | Hereditary Gastrointestinal Cancer Panel, Sequencing and Deletion/Duplication | |
2012032 | Hereditary Cancer Panel, Sequencing and Deletion/Duplication | |
3001605 | Lynch Syndrome Panel, Sequencing and Deletion/Duplication | |
3004407 | APC- and MUTYH-Associated Polyposis Panel, Sequencing and Deletion/Duplication | |
0051750 | BRAF Codon 600 Mutation Detection with Reflex to MLH1 Promoter Methylation | |
3004308 | MLH1 Promoter Methylation | |
0049302 | Mismatch Repair by Immunohistochemistry | |
3004277 | Microsatellite Instability (MSI) HNPCC/Lynch Syndrome by PCR | |
2005270 | Mismatch Repair by Immunohistochemistry with Reflex to MLH1 Promoter Methylation | |
Gaucher Disease |
3001648 | Gaucher Disease (GBA) Sequencing | |
0051438 | Gaucher Disease (GBA), 8 Variants | |
2014459 | Gaucher Disease (GBA), Enzyme Activity in Leukocytes | |
Genome |
3005928 | Rapid Whole Genome Sequencing, Familial Control | |
3005933 | Rapid Whole Genome Sequencing, Familial Control with Report | |
3005935 | Rapid Whole Genome Sequencing | |
3016493 | Whole Genome Sequencing | |
3016497 | Whole Genome Sequencing, Familial Control | |
3005939 | Whole Genome Reanalysis | |
Genomic Microarray |
2003414 | Cytogenomic SNP Microarray | |
2006267 | Cytogenomic SNP Microarray Buccal Swab | |
2006325 | Cytogenomic SNP Microarray—Oncology | |
2002366 | Cytogenomic SNP Microarray—Fetal | |
2005633 | Genomic SNP Microarray, Products of Conception | |
3004273 | Cytogenomic Molecular Inversion Probe Array, FFPE Tissue - Products of Conception | |
Glutarylcarnitine |
2001510 | Glutarylcarnitine, Quantitative, Urine | |
Hearing Loss |
3004720 | Connexin 26 (GJB2) Sequencing and Deletion/Duplication | |
2001956 | Hearing Loss, Nonsyndromic, Connexin 30 (GJB6) 2 Deletions | |
Hemoglobinopathies |
2005792 | Hemoglobin Evaluation Reflexive Cascade | |
3000894 | Hereditary Hemolytic Anemia Cascade | |
3004547 | Beta Globin (HBB) Gene Sequencing | |
3003144 | Deletion/Duplication Analysis by MLPA | |
3004550 | Beta Globin (HBB) Sequencing, Fetal | |
2011708 | Alpha Globin (HBA1 and HBA2) Sequencing and Deletion/Duplication | |
3003651 | Alpha Thalassemia (HBA1 and HBA2) Deletion/Duplication with Reflex to Hb Constant Spring | |
2011622 | Alpha Globin (HBA1 and HBA2) Deletion/Duplication | |
3003656 | Alpha Thalassemia (HBA1 and HBA2) Deletion/Duplication with Reflex to Hb Constant Spring, Fetal | |
3001957 | Gamma Globin (HBG1 and HBG2) Sequencing | |
0050610 | Hemoglobin Evaluation with Reflex to Electrophoresis and/or RBC Solubility | |
0050520 | Hemoglobin S, Evaluation with Reflex to RBC Solubility | |
2013399 | Hemoglobin S, Sickle Solubility | |
0049090 | Heinz Body Stain | |
0049020 | Hemoglobin, Unstable | |
Hemophilia |
3004232 | Hemophilia A (F8) 2 Inversions with Reflex to Sequencing and Reflex to Deletion/Duplication | |
2001759 | Hemophilia A (F8) 2 Inversions | |
3004241 | Hemophilia A (F8) Sequencing | |
2001755 | Hemophilia A (F8) 2 Inversions, Fetal | |
Hereditary Hemochromatosis |
0055656 | Hereditary Hemochromatosis Mutation Detection (C282Y, H63D, & S65C) | |
Hereditary Hemolytic Anemia |
3000894 | Hereditary Hemolytic Anemia Cascade | |
2012052 | Hereditary Hemolytic Anemia Panel, Sequencing | |
Hereditary Hemorrhagic Telangiectasia (HHT) |
2009337 | Hereditary Hemorrhagic Telangiectasia (HHT) Panel, Sequencing and Deletion/Duplication | |
2007384 | Vascular Malformations Panel, Sequencing and Deletion/Duplication, 10 Genes | |
Hereditary Myeloid Neoplasms |
3001842 | Hereditary Myeloid Neoplasms Panel, Sequencing | |
Hereditary Paraganglioma-Pheochromocytoma Syndromes |
3005912 | Hereditary Paraganglioma-Pheochromocytoma Expanded Panel, Sequencing and Deletion/Duplication | |
3004480 | Hereditary Paraganglioma-Pheochromocytoma (SDHA, SDHB, SDHC, and SDHD) Panel, Sequencing and Deletion/Duplication | |
Heterotaxy/Situs Inversus |
3002682 | Heterotaxy and Situs Inversus Panel, Sequencing | |
3001621 | Primary Ciliary Dyskinesia Panel, Sequencing | |
HLA Testing |
3002307 | HLA Class I Panel (ABC) by Next Generation Sequencing | |
3002061 | HLA Class I and II Panel (A,B,C,DRB1, DQA1, DQB1, DPB1) by Next Generation Sequencing | |
3002062 | HLA Class I and II Panel (A,B,C,DRB1, DRB345, DQA1, DQB1, DPA1, DPB1) by Next Generation Sequencing | |
3002308 | HLA Class II Panel (DRB1, DQA1 and DQB1) by Next Generation Sequencing | |
2012494 | HLA-DRB1 by Next Generation Sequencing | |
HLA-B Pharmacogenetic Testing |
2012049 | HLA-B*15:02 Genotyping, Carbamazepine Hypersensitivity | |
3017549 | HLA-B51 Genotyping, Behcet Disease | |
2002429 | HLA-B*5701 Associated Variant Genotyping for Abacavir Sensitivity | |
3001393 | HLA-B*58:01 Genotyping, Allopurinol Hypersensitivity | |
HLA-B27 (Ankylosing Spondylitis) Genotyping |
0050392 | Ankylosing Spondylitis (HLA-B27) Genotyping | |
Holoprosencephaly |
2008848 | Holoprosencephaly Panel, Sequencing and Deletion/Duplication | |
2008863 | Holoprosencephaly Panel, Sequencing and Deletion/Duplication, Fetal | |
Huntington Disease |
3016908 | Huntington Disease (HD) CAG Repeat Expansion | |
Kell Antigen Genotyping |
3002001 | Kell K/k Antigen (KEL) Genotyping | |
Loeys-Dietz Syndrome |
3003947 | Loeys-Dietz Syndrome Core Panel, Sequencing | |
Lynch Syndrome |
3001605 | Lynch Syndrome Panel, Sequencing and Deletion/Duplication | |
0051750 | BRAF Codon 600 Mutation Detection with Reflex to MLH1 Promoter Methylation | |
3004308 | MLH1 Promoter Methylation | |
0049302 | Mismatch Repair by Immunohistochemistry | |
3004277 | Microsatellite Instability (MSI) HNPCC/Lynch Syndrome by PCR | |
2005270 | Mismatch Repair by Immunohistochemistry with Reflex to MLH1 Promoter Methylation | |
Lysosomal Acid Lipase |
2012266 | Lysosomal Acid Lipase Activity, Dried Blood Spot | |
Malignant Hyperthermia Susceptibility |
3002688 | Malignant Hyperthermia Panel, Sequencing | |
Methylenetetrahydrofolate Reductase (MTHFR) |
0055655 | Methylenetetrahydrofolate Reductase (MTHFR) 2 Mutations | |
Methylmalonic Acid |
2005255 | Methylmalonic Acid, Serum or Plasma (Metabolic Disorders) | |
Mitochondrial Disorders |
3001959 | Mitochondrial Disorders Panel (mtDNA and Nuclear Genes) | |
3001965 | Mitochondrial Disorders (mtDNA) Sequencing and Deletion Analysis by NGS | |
MODY and Neonatal Diabetes |
3001593 | MODY and Neonatal Diabetes Panel, Sequencing | |
Mucolipidosis IV |
2012259 | Keratan Sulfate, Quantitative by LC-MS/MS, Urine | |
0051448 | Mucolipidosis Type IV (MCOLN1), 2 Variants | |
Mucopolysaccharidoses (MPS) |
0081352 | Mucopolysaccharides Electrophoresis and Quantitation, Urine | |
0081357 | Mucopolysaccharides, Quantitative, Urine | |
2011415 | Alpha-Iduronidase Enzyme Activity in Leukocytes | |
3003566 | Mucopolysaccharidoses Type 1/2, Total Heparan Sulfate and NRE (Sensi-Pro®) Quantitative, Serum or Plasma | |
3003552 | Mucopolysaccharidoses Type 1/2, Total Heparan Sulfate and NRE (Sensi-Pro®) Quantitative, Urine | |
3003487 | Mucopolysaccharidoses Type 4A/6 Total Chondroitin Sulfate and Dermatan Sulfate with NRE (Sensi-Pro®) Quantitative, Serum | |
3003539 | Mucopolysaccharidoses Type 4A/6 Total CS-DS and NRE (Sensi-Pro®) Quantitative, Urine | |
Multiple Endocrine Neoplasia |
3004437 | Multiple Endocrine Neoplasia Type 1 (MEN1) Sequencing and Deletion/Duplication | |
3004572 | Multiple Endocrine Neoplasia Type 2 (MEN2), RET Sequencing | |
Muscular Dystrophy |
2011241 | Duchenne/Becker Muscular Dystrophy (DMD) Deletion/Duplication with Reflex to Sequencing | |
2011235 | Duchenne/Becker Muscular Dystrophy (DMD) Deletion/Duplication | |
2011153 | Duchenne/Becker Muscular Dystrophy (DMD) Sequencing | |
2011231 | Duchenne/Becker Muscular Dystrophy (DMD) Deletion/Duplication, Fetal | |
3001839 | Emery-Dreifuss Muscular Dystrophy Panel, Sequencing | |
3001907 | Myotonic Dystrophy Type 1 (DMPK) CTG Expansion | |
Narcolepsy |
2005023 | Narcolepsy (HLA-DQB1*06:02) Genotyping | |
Neurofibromatosis Type 1 and Legius Syndrome |
3003927 | Neurofibromatosis Type 1 and Legius Syndrome Panel, Sequencing and Deletion/Duplication | |
Non-Alcoholic Fatty Liver Disease |
2014599 | Non-Alcoholic Fatty Liver Disease Susceptibility (PNPLA3) Genotyping | |
Non-Invasive Prenatal Aneuploidy Screen (Cell-Free DNA) |
3003043 | Non-Invasive Prenatal Aneuploidy Screen by cell-free DNA Sequencing | |
Noonan Syndrome |
2010772 | Noonan Spectrum Disorders Panel, Sequencing | |
2010769 | Noonan Spectrum Disorders Panel, Sequencing, Fetal | |
Oncology Studies |
2002292 | Chromosome Analysis, Bone Marrow | |
2002290 | Chromosome Analysis, Leukemic Blood | |
2007130 | Bone Marrow, Chromosome Analysis with Reflex to Genomic Microarray | |
2007131 | Leukemic Blood, Chromosome Analysis with Reflex to Genomic Microarray | |
2002300 | Chromosome Analysis, Lymph Node | |
2002296 | Chromosome Analysis, Solid Tumor | |
Oncology Studies, FISH—Blood and Bone Marrow Panels |
2002647 | Acute Lymphocytic Leukemia (ALL) Panel by FISH, Adult | |
2002719 | Acute Lymphocytic Leukemia (ALL) Panel by FISH, Pediatric | |
2002653 | Acute Myelogenous Leukemia (AML) with Myelodysplastic Syndrome (MDS), or Therapy-Related AML, by FISH | |
3016654 | Acute Myelogenous Leukemia Panel by FISH | |
2002295 | Chromosome FISH, CLL Panel | |
2006270 | Chromosome FISH, Multiple Myeloma Panel Process and Hold | |
2002378 | Eosinophilia Panel by FISH | |
3002737 | FISH, Interphase, CD138+ Cells | |
2002650 | Lymphoma (Aggressive) Panel by FISH | |
3002063 | Multiple Myeloma Panel by FISH | |
2002709 | Myelodysplastic Syndrome (MDS) Panel by FISH | |
2002360 | Myeloproliferative Disorders Panel by FISH | |
2002363 | PML/RARα Translocation by FISH | |
Oncology Studies, FISH—Blood and Bone Marrow—by Gene/Probe |
2002298 | Chromosome FISH, Interphase—ASS1; +9/9q34 | |
2002298 | Chromosome FISH, Interphase—ATM; del(11)(q22.3) | |
2002298 | Chromosome FISH, Interphase—BCL6; 3q27 | |
2002298 | Chromosome FISH, Interphase—BCR-ABL1; t(9;22)(q34;q11.2) | |
2002298 | Chromosome FISH, Interphase—CBFB; inv(16)(p13.3q22)/t(16;16)(p13;q22) | |
2002298 | Chromosome FISH, Interphase—CCND1-IGH@; t(11;14)(q13;q32) | |
2002298 | Chromosome FISH, Interphase—Chromosome 10, centromere | |
2002298 | Chromosome FISH, Interphase—Chromosome 4, centromere | |
2002298 | Chromosome FISH, Interphase—Chromosome 8, centromere | |
2002298 | Chromosome FISH, Interphase—CKS1B; 1q21 | |
2002298 | Chromosome FISH, Interphase—D12Z3; +12 | |
2002298 | Chromosome FISH, Interphase—D13S319; del(13)(q14.3) | |
2002298 | Chromosome FISH, Interphase—D20S108; del(20)(q12) | |
2002298 | Chromosome FISH, Interphase—D7S486; del(7)(q31)/-7 | |
2002298 | Chromosome FISH, Interphase—DDIT3 (CHOP); 12q13 | |
2002298 | Chromosome FISH, Interphase—EGR1; del(5)(q31) | |
2002298 | Chromosome FISH, Interphase—ETV6-RUNX1 (TEL-AML1); t(12;21)(p13;q22) | |
2002298 | Chromosome FISH, Interphase—EWSR1; 22q12.2 | |
2002298 | Chromosome FISH, Interphase—FGFR1; 8p12 | |
2002298 | Chromosome FISH, Interphase—FGFR3-IGH@; t(4;14)(p16;q32) | |
2002298 | Chromosome FISH, Interphase—IGH@-BCL2; t(14;18)(q32;q21) | |
2002298 | Chromosome FISH, Interphase—IGH@-MAF; t(14;16)(q32;q23.1) | |
2002298 | Chromosome FISH, Interphase—IGH@; 14q32 | |
2002298 | Chromosome FISH, Interphase—MALT1; 18q21 | |
2002298 | Chromosome FISH, Interphase—MLL; 11q23 | |
2002298 | Chromosome FISH, Interphase—MYC; 8q24 | |
2002298 | Chromosome FISH, Interphase—PDGFRα-CHIC2-FIP1L1; 4q12 | |
2002298 | Chromosome FISH, Interphase—PDGFRβ; 5q32 | |
2002298 | Chromosome FISH, Interphase—PML-RARA; t(15;17)(q22;q21) | |
2002298 | Chromosome FISH, Interphase—PML; +15 | |
2002298 | Chromosome FISH, Interphase—RUNX1T1-RUNX1 (ETO-AML1); t(8;21)(q22;q22) | |
2002298 | Chromosome FISH, Interphase—SS18 (SYT); 18q11.2 | |
2002298 | Chromosome FISH, Interphase—TCF3 (E2A); 19p13 | |
2002298 | Chromosome FISH, Interphase—TP53 (p53); del(17)(p13.1) | |
Oncology Studies, FISH—Other |
2002528 | Pancreatobiliary FISH | |
Oncology Studies, FISH—Paraffin Block |
3001309 | 1p/19q Deletion by FISH | |
3001495 | Aggressive B-Cell Lymphoma Reflex Panel by FISH, Tissue | |
3001302 | ALK Gene Rearrangements by FISH, Lung | |
3001311 | BCL6 (3q27) Gene Rearrangement by FISH | |
3001304 | DDIT3 (CHOP) (12q13) Gene Rearrangement by FISH | |
3001310 | EGFR Gene Amplification by FISH | |
2008603 | ERBB2 (HER-2/neu) Gene Amplification by FISH, Tissue | |
3001305 | EWSR1 (22q12) Gene Rearrangement by FISH | |
3001297 | FOXO1 (FKHR) (13q14) Gene Rearrangement by FISH | |
3000548 | FUS (16p11) Gene Rearrangement by FISH | |
3001298 | IGH-BCL2 Fusion, t(14;18) by FISH for Detection in Follicular Lymphoma | |
3001306 | IGH-CCND1 Fusion, t(11;14) by FISH | |
3001299 | IGH-MYC Fusion t(8;14) by FISH | |
3001568 | IRF4/DUSP22 (6p25) Gene Rearrangement by FISH | |
3001313 | MET Gene Amplification by FISH | |
3001301 | MDM2 Gene Amplification by FISH | |
3001300 | MYC (8q24) Gene Rearrangement by FISH | |
3001307 | MYCN (N-MYC) Gene Amplification by FISH | |
3001312 | RET Gene Rearrangements by FISH | |
3001308 | ROS1 by FISH | |
3001303 | SS18 (SYT) (18q11) Gene Rearrangement by FISH | |
Oncology Studies, Microarray |
2007130 | Bone Marrow, Chromosome Analysis with Reflex to Genomic Microarray | |
2007131 | Leukemic Blood, Chromosome Analysis with Reflex to Genomic Microarray | |
3004275 | Cytogenomic Molecular Inversion Probe Array FFPE Tissue – Oncology | |
2006325 | Cytogenomic SNP Microarray—Oncology | |
Opioid Receptor, Mu |
2008767 | Opioid Receptor, Mu (OPRM1) Genotype, 1 Variant | |
Organic Acids |
0098389 | Organic Acids, Urine | |
Orotic Acid |
3000704 | Orotic Acid, Urine | |
Osteogenesis Imperfecta |
3001607 | Osteogenesis Imperfecta and Low Bone Density Panel, Sequencing | |
Ovarian Cancer |
2012026 | Hereditary Breast and Gynecological Cancers Panel, Sequencing and Deletion/Duplication | |
3001855 | BRCA1 and BRCA2-Associated HBOC Syndrome Panel, Sequencing and Deletion/Duplication | |
2012032 | Hereditary Cancer Panel, Sequencing and Deletion/Duplication | |
Pancreatic Cancer |
3005708 | Hereditary Pancreatic Cancer Panel, Sequencing and Deletion/Duplication | |
Pancreatitis |
3004788 | Pancreatitis, Panel (CFTR, CTRC, PRSS1, SPINK1) Sequencing | |
Periodic Fever Syndromes |
2007370 | Periodic Fever Syndromes Panel, Sequencing and Deletion/Duplication | |
3004434 | Familial Mediterranean Fever (MEFV) Sequencing | |
Peroxisomal Disorders |
3002700 | Peroxisomal Disorders Panel, Sequencing | |
Pharmacogenetics Panels |
3004471 | Pharmacogenetics Panel: Psychotropics | |
3006366 | Pharmacogenetics Panel: Psychotropics, with GeneDose Access | |
Phenylalanine |
0080336 | Phenylalanine and Tyrosine, Plasma (monitoring only) | |
0080315 | Phenylalanine Monitoring, Plasma (monitoring only) | |
Pipecolic Acid |
2007406 | Pipecolic Acid, Serum or Plasma | |
2008131 | Pipecolic Acid, Urine | |
Plasminogen Activator Inhibitor-1 |
2004980 | Plasminogen Activator Inhibitor-1, PAI-1 (SERPINE1) Genotyping | |
Platelet Antigen Genotyping |
3000193 | Platelet Antigen Genotyping Panel | |
3016673 | Platelet Antigen Genotyping Panel, Fetal | |
Pompe Disease |
2014463 | Pompe Disease (GAA), Enzyme Activity in Leukocytes | |
Prader-Willi Syndrome |
3006247 | Angelman Syndrome and Prader-Willi Syndrome by Methylation-Specific MLPA | |
2002299 | Chromosome FISH, Metaphase—Prader-Willi syndrome (15q11.2-13) | |
Primary Antibody Deficiency |
2011156 | Primary Antibody Deficiency Panel, Sequencing and Deletion/Duplication | |
Prostate Cancer |
3005686 | Hereditary Prostate Cancer Panel, Sequencing and Deletion/Duplication | |
Prothrombin (Factor II) |
0056060 | Prothrombin Nucleotide 20210 G/A Gene Mutation (Factor II) | |
Pulmonary Arterial Hypertension (PAH) |
2009345 | Pulmonary Arterial Hypertension (PAH) Panel, Sequencing and Deletion/Duplication | |
Renal Cancer |
2010214 | Hereditary Renal Cancer Panel, Sequencing and Deletion/Duplication | |
2012032 | Hereditary Cancer Panel, Sequencing and Deletion/Duplication | |
Retinoblastoma |
3005696 | Hereditary Retinoblastoma (RB1) Sequencing and Deletion/Duplication | |
Rh Genotyping |
0051368 | Rh Genotyping D Antigen (RhD positive/negative and RhD copy number) | |
3002002 | RhC/c (RHCE) Antigen Genotyping | |
3002003 | RhE/e (RHCE) Antigen Genotyping | |
Schwachman-Diamond Syndrome |
2006240 | Schwachman-Diamond Syndrome (SBDS) Sequencing | |
Serum Screening—First- and Second-Trimester Combined |
3000147 | Maternal Serum Screening, Integrated, Specimen #1, PAPP-A, NT | |
3000149 | Maternal Serum Screening, Integrated, Specimen #2, Alpha Fetoprotein, hCG, Estriol, and Inhibin A | |
3000146 | Maternal Screening, Sequential, Specimen #1, hCG, PAPP-A, NT | |
3000148 | Maternal Screening, Sequential, Specimen #2, Alpha Fetoprotein, hCG, Estriol, and Inhibin A | |
Serum Screening—First-Trimester |
3000145 | Maternal Serum Screen, First Trimester, hCG, PAPP-A, NT | |
Serum Screening—Second-Trimester |
3000144 | Maternal Serum Screen, Alpha Fetoprotein | |
3000143 | Maternal Serum Screen, Alpha Fetoprotein, hCG, Estriol, and Inhibin A (Quad) | |
SHOX Deficiency Disorders |
3004603 | SHOX Deficiency Disorders, Sequencing and Deletion/Duplication | |
3003144 | Deletion/Duplication Analysis by MLPA | |
Skeletal Dysplasia |
2012010 | Skeletal Dysplasia Panel, Sequencing and Deletion/Duplication, Fetal | |
2012015 | Skeletal Dysplasia Panel, Sequencing and Deletion/Duplication | |
Skin Cancer |
3002673 | Hereditary Melanoma Panel, Sequencing and Deletion/Duplication | |
Spinal Muscular Atrophy (SMA) |
2013436 | Spinal Muscular Atrophy (SMA) Copy Number Analysis | |
2013444 | Spinal Muscular Atrophy (SMA) Copy Number Analysis, Fetal | |
Statin Sensitivity |
2008426 | SLCO1B1, 1 Variant | |
Stickler Syndrome |
3001613 | Stickler Syndrome Panel, Sequencing | |
Succinylacetone |
2007401 | Succinylacetone, Quantitative, Urine | |
Tay-Sachs Disease |
3004486 | Tay-Sachs Disease (HEXA) Sequencing and Deletion/Duplication | |
0051428 | Tay-Sachs Disease (HEXA), 7 Variants | |
Thanatophoric Dysplasia |
0051506 | Thanatophoric Dysplasia, Types 1 and 2 (FGFR3) 13 Mutations | |
0051508 | Thanatophoric Dysplasia, Types 1 and 2 (FGFR3) 13 Mutations, Fetal | |
Thiopurine Methyltransferase |
3017372 | TPMT Genotyping | |
3017373 | NUDT15 Genotyping | |
3001535 | TPMT and NUDT15 | |
Thrombotic Risk |
0030133 | Thrombotic Risk, Inherited Etiologies (Most Common) with Reflex to Factor V Leiden | |
0056200 | Thrombotic Risk, DNA Panel (FVL, Factor II, MTHFR) | |
Thyroid Cancer |
3005944 | Hereditary Thyroid Cancer Panel, Sequencing and Deletion/Duplication | |
Tuberous Sclerosis Complex |
3002100 | Tuberous Sclerosis Complex Panel, Sequencing and Deletion/Duplication | |
3002096 | Tuberous Sclerosis Complex Panel, Sequencing and Deletion/Duplication, Fetal | |
Twin Zygosity Testing |
3016875 | Twin Zygosity | |
Tyrosine |
0080355 | Tyrosine, Plasma | |
UGT1A1 Gene Analysis |
3004386 | UGT1A1 Sequencing | |
0051332 | UDP Glucuronosyltransferase 1A1 (UGT1A1) Genotyping | |
Vascular Malformation Syndromes |
2007384 | Vascular Malformations Panel, Sequencing and Deletion/Duplication | |
2009337 | Hereditary Hemorrhagic Telangiectasia (HHT) Panel, Sequencing and Deletion/Duplication | |
3002286 | Cerebral Cavernous Malformation Panel, Sequencing and Deletion/Duplication | |
3003634 | Capillary Malformation-Arteriovenous Malformation (CM-AVM) Panel, Sequencing and Deletion/Duplication | |
3003144 | Deletion/Duplication Analysis by MLPA | |
Von Willebrand Disease |
3004379 | von Willebrand Disease (VWF) Sequencing | |
Warfarin Genotyping |
3001541 | Warfarin Sensitivity (CYP2C9, CYP2C cluster, CYP4F2, VKORC1) Genotyping | |
Wilson Disease |
3004411 | Wilson Disease (ATP7B) Sequencing | |
X-Chromosome Inactivation |
2006352 | X-Chromosome Inactivation Analysis | |
Y Chromosome Microdeletion |
2001778 | Y Chromosome Microdeletion | |